Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Technosphere Insulin Formulations vs Lispro in T1DM
NCT00662857Phase 2Completed
- Sponsor
- MannKind
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of TI-Inhalation Powder B in type 1 diabetes mellitus (T1D) (3 arms), sponsored by MannKind. Primary endpoints: Area Under the Curve 0-360 min, Maximum Concentration and 2 more. Started Apr 2008; status: completed.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00662857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662857.